MCSTAP Guideline Update: A Series on Applying the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Assessing Risk of Opioid Therapy: Applying the 2022 CDC Guidelines - April 19, 2023

This site is for learners who attended the live April 19, 2023, program to claim credit.

Claiming Credit 

Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.

Target Audience

Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Understand key components of the CDC Guidelines for Prescribing Opioids for Pain
  • Improve communications with patients about benefits and risks of pain treatment as well as the safety and efficacy of pain treatment
  • Understand the implications of the guidelines on treatment of patients with chronic pain and opioid use disorder
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Course opens: 
04/19/2023
Course expires: 
04/30/2024
Rating: 
0
Christopher Shanahan, MD, MPH, FACP
MCSTAP Medical Director, CME Course Director
 
Presenters
Christopher Shanahan, MD, MPH, FACP, James Ledwith, Jr., MD and Jason Worcester, MD
 
CME Operations Manager: Naomi Moeller

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.

ADA statement: To request reasonable accommodations for a disability please contact MCSTAP@beaconhealthoptions.com, in writing, at least two weeks prior to the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Opioid Education Statement
  • 1.00 Participation
Please login or register to take this course.